Latest news

A third of leukaemia patients do not generate any antibody response to two doses of COVID-19 vaccination, study shows

A third of leukaemia patients do not generate any antibody response to two doses of COVID-19 vaccination, study shows
Description
A University of Birmingham-led study has shown that a third of patients with the most common type of leukaemia fail to generate any measurable antibody response following two doses of COVID-19 vaccination.
Date:
22/10/2021

Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway

Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway
Description
Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
Date:
11/10/2021

Research provides new insight into fundamental workings of the immune system in response to therapy to treat skin cancer

Research provides new insight into fundamental workings of the immune system in response to therapy to treat skin cancer
Description
New research suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.
Date:
16/09/2021

University of Birmingham scientists in new COVID-19 study

University of Birmingham scientists in new COVID-19 study
Description
University of Birmingham researchers are part of a new study seeking to understand why some people become infected with COVID-19 after vaccination or prior infection while others do not.
Date:
14/09/2021

Birmingham cancer project enters Immuno-oncology Alliance

Birmingham cancer project enters Immuno-oncology Alliance
Description
Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.
Date:
29/07/2021

Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells

Longer interval between the first and second Pfizer vaccine boosts antibody levels and 'helper' T cells
Description
A new study carried out in collaboration with the University of Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses.
Date:
23/07/2021

Partnership will create the next generation of researchers to transform global healthcare

Partnership will create the next generation of researchers to transform global healthcare
Description
The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
Date:
13/07/2021

Cancer Research UK Advanced Clinician Scientist shares top tips on undertaking research

Description
Dr Shishir Shetty is a Cancer Research UK Advanced Clinician Scientist and principal investigator in the Centre for Liver and Gastrointestinal Research.
Date:
07/07/2021

Congress focuses on impact of COVID-19 on global liver disease

Congress focuses on impact of COVID-19 on global liver disease
Description
University of Birmingham experts are among the leading liver disease researchers gathering at the virtual 2021 International Liver Congress to discuss the impact of the COVID-19 pandemic on people with liver disease.
Date:
25/06/2021

Fighting the silent pandemic of anti-microbial resistance

Fighting the silent pandemic of anti-microbial resistance
Description
An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.
Date:
11/06/2021
Displaying 1 to 10 of 140
Previous 1 2 3 4 5 Next